Filed Pursuant to Rule 424(b)(5)
Registration No. 333-223441
PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED MARCH 16, 2018
Republic of Indonesia
€1,000,000,000 1.100% Bonds Due 2033
US$1,250,000,000 1.850% Bonds Due 2031
US$1,250,000,000 3.050% Bonds Due 2051
US$500,000,000 3.350% Bonds Due 2071
The Republic of Indonesia (the “Republic”) is offering €1,000,000,000 in aggregate principal amount of its 1.100% bonds due 2033 (the “2033 Bonds”), US$1,250,000,000 in aggregate principal amount of its 1.850% bonds due 2031 (the “2031 Bonds”), US$1,250,000,000 in aggregate principal amount of its 3.050% bonds due 2051 (the “2051 Bonds”) and US$500,000,000 in aggregate principal amount of its 3.350% bonds due 2071 (the “2071 Bonds,” and, together with the 2033 Bonds, the 2031 Bonds and the 2051 Bonds, the “Bonds”). Interest on the 2033 Bonds will accrue from January 12, 2021 and be payable annually in arrears on March 12 of each year, beginning on March 12, 2022 until redemption or maturity. Interest on the 2031 Bonds, the 2051 Bonds and the 2071 Bonds will accrue from January 12, 2021 and be payable semi-annually in arrears on March 12 and September 12 of each year, beginning on September 12, 2021 until redemption or maturity.
The Bonds contain “collective action clauses.” Under these provisions, which differ from the terms of the Republic’s public external indebtedness issued prior to January 8, 2015, modifications affecting the reserve matters listed in the indenture, including modifications to payment and other important terms, may be made to a single series of debt securities issued under the indenture (including the Bonds) with the consent of the holders of 75% of the aggregate principal amount outstanding of that series, and to two or more series of debt securities issued under the indenture either (x) with the consent of holders of 75% of the aggregate principal amount of the outstanding debt securities of all the series affected by the proposed modification (taken in aggregate) if the modification is uniformly applicable; or (y) with the consent of the holders of 662/3% of the aggregate principal amount outstanding of all series of debt securities that would be affected and 50% in aggregate principal amount outstanding of each affected series of debt securities.
Approval in-principle has been granted for the listing of the Bonds on the Singapore Exchange Securities Trading Limited (“SGX-ST”) and the Open Market of the Frankfurt Stock Exchange. The SGX-ST assumes no responsibility for the correctness of any of the statements made or opinions or reports contained in this prospectus supplement and the accompanying prospectus. Admission of the Bonds to the official list of the SGX-ST is not to be taken as an indication of the merits of the Republic or the Bonds.
You should read this prospectus supplement and the accompanying prospectus carefully. You should not assume that the information in this prospectus supplement and the accompanying prospectus is accurate as of any date other than the date on the front of these documents.
The Euro-denominated Bonds will be represented by one or more global Bonds registered in the name of a nominee of the common depositary for Euroclear Bank, S.A./N.V. (“Euroclear” or the “Euroclear System”) and Clearstream Banking, S.A. (“Clearstream” or “Clearstream, Luxembourg”), and the U.S. dollar-denominated Bonds will be represented by one or more global Bonds registered in the name of a nominee of The Depository Trust Company (“DTC”), as depositary. The Republic expects to deliver the Bonds to investors in registered book-entry form only through the facilities of DTC for the U.S. dollar-denominated Bonds and Clearstream, Luxembourg and Euroclear for the Euro-denominated Bonds, on or about January 12, 2021.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2033 Bonds | | | 2031 Bonds | | | 2051 Bonds | | | 2071 Bonds | |
| | Per Bond | | | Total | | | Per Bond | | | Total | | | Per Bond | | | Total | | | Per Bond | | | Total | |
Price to investors | | | 99.165 | % | | € | 991,650,000 | | | | 99.538 | % | | US$ | 1,244,225,000 | | | | 99.020 | % | | US$ | 1,237,750,000 | | | | 98.794 | % | | US$ | 493,970,000 | |
Underwriting discounts and commissions | | | 0.040 | % | | € | 396,660 | | | | 0.040 | % | | US$ | 497,690 | | | | 0.040 | % | | US$ | 495,100 | | | | 0.040 | % | | US$ | 197,588 | |
Proceeds, before expenses, to the Republic | | | 99.125 | % | | € | 991,253,340 | | | | 99.498 | % | | US$ | 1,243,727,310 | | | | 98.980 | % | | US$ | 1,237,254,900 | | | | 98.754 | % | | US$ | 493,772,412 | |
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
Joint Lead Managers and Joint Bookrunners
| | | | | | | | |
Citigroup | | DBS Bank Ltd. | | Deutsche Bank | | Mandiri Securities | | Standard Chartered Bank |
Co-Managers
| | |
PT BRI Danareksa Sekuritas | | PT Trimegah Sekuritas Indonesia Tbk |
The date of this prospectus supplement is January 5, 2021.